What does RADIOLOGIE SCHEPENS do?

RADIOLOGIE SCHEPENS is a specialist medical practice in Gent. Private Limited, started on 13 September 2007, 1 establishment.

What is the address of RADIOLOGIE SCHEPENS?

The registered office of RADIOLOGIE SCHEPENS is located at Tentoonstellingslaan 95, 9000 Gent.

Is RADIOLOGIE SCHEPENS still active?

Yes. According to the CBE (2 November 2026) RADIOLOGIE SCHEPENS is active, legal situation “Normale toestand”, started on 13 September 2007.

Is RADIOLOGIE SCHEPENS registered on Peppol?

Yes, RADIOLOGIE SCHEPENS is registered on the Peppol network with ID 0208:0892033081.

What is the enterprise number of RADIOLOGIE SCHEPENS?

The enterprise number of RADIOLOGIE SCHEPENS is BE0892033081.

When was RADIOLOGIE SCHEPENS founded?

RADIOLOGIE SCHEPENS was founded on 13 September 2007.

Who are the directors of RADIOLOGIE SCHEPENS?

According to the 2026 annual accounts, the directors of RADIOLOGIE SCHEPENS are: Filiz Özsarlak, Elisabeth Schepens.

Is RADIOLOGIE SCHEPENS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 September 2007; 5 annual accounts filed, latest fiscal year 2026; 2 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did RADIOLOGIE SCHEPENS make in 2026?

RADIOLOGIE SCHEPENS recorded a loss after taxes of € 100,836 in financial year 2026.

What is the revenue of RADIOLOGIE SCHEPENS?

As a small company, RADIOLOGIE SCHEPENS is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 62,784.

RADIOLOGIE SCHEPENS (Private Limited) - Gent

Dossier RADIOLOGIE SCHEPENS, printed on 3 November 2026 from databakkes.be/en/0892033081/radiologie-schepens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 1 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2025 and 2026.
Tight liquidity NBB

Cash and receivables cover 27 % of short-term debt in 2026; threshold 65 %.

Financials

Financial year 2026

RADIOLOGIE SCHEPENS from Gent, company number BE0892033081, closed financial year 2026 with a result of € -100,836 after tax. For that financial year RADIOLOGIE SCHEPENS recorded a gross margin of € 62,784 and equity of € -24,181. Compared with financial year 2025, the result moved from € -23,894 to € -100,836. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 6, 2026.

What it is worth Caution

€ -24,181

▼ € 100,836 vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -100,836

▼ 322 % more loss than in 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 9,168

▼ 95% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -42,781.

People and assets in 2026

Wage cost

€ 46,412

▲ 5% vs 2025

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 25,369

▼ 29% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 488,792

▼ 17% vs 2025

€ 90,958 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 13,743

▼ 12% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 6,285

▼ 56% vs 2025

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 130,775 Gross margin 2023: € 130,775 First fiscal year in the series	€ 153,157 Gross margin 2024: € 153,157 ▲ 17% vs 2023 (€ 130,775) Favourable step	€ 121,212 Gross margin 2025: € 121,212 ▼ 21% vs 2024 (€ 153,157) Unfavourable step	€ 62,784 Gross margin 2026: € 62,784 ▼ 48% vs 2025 (€ 121,212) Unfavourable step	▼ 48%
Profit after taxes	€ 45,022 Profit after taxes 2023: € 45,022 First fiscal year in the series	€ 36,928 Profit after taxes 2024: € 36,928 ▼ 18% vs 2023 (€ 45,022) Unfavourable step	€ -23,894 Profit after taxes 2025: € -23,894 ▼ € 60,822 vs 2024 (€ 36,928) Unfavourable step	€ -100,836 Profit after taxes 2026: € -100,836 ▼ € 76,942 vs 2025 (€ -23,894) Unfavourable step	▼ € 76,942
Equity	€ 287,611 Equity 2023: € 287,611 First fiscal year in the series	€ 218,131 Equity 2024: € 218,131 ▼ 24% vs 2023 (€ 287,611) Unfavourable step	€ 76,656 Equity 2025: € 76,656 ▼ 65% vs 2024 (€ 218,131) Unfavourable step	€ -24,181 Equity 2026: € -24,181 ▼ € 100,836 vs 2025 (€ 76,656) Unfavourable step	▼ € 100,836
Total debts	€ 522,653 Total debts 2023: € 522,653 First fiscal year in the series	€ 495,847 Total debts 2024: € 495,847 ▼ 5% vs 2023 (€ 522,653) Favourable step	€ 737,290 Total debts 2025: € 737,290 ▲ 49% vs 2024 (€ 495,847) Unfavourable step	€ 534,696 Total debts 2026: € 534,696 ▼ 27% vs 2025 (€ 737,290) Favourable step	▼ 27%
Cash	€ 136,601 Cash 2023: € 136,601 First fiscal year in the series	€ 63,073 Cash 2024: € 63,073 ▼ 54% vs 2023 (€ 136,601) Unfavourable step	€ 189,633 Cash 2025: € 189,633 ▲ 201% vs 2024 (€ 63,073) Favourable step	€ 9,168 Cash 2026: € 9,168 ▼ 95% vs 2025 (€ 189,633) Unfavourable step	▼ 95%
Land & buildings	€ 349,589 Land & buildings 2023: € 349,589 First fiscal year in the series	€ 313,052 Land & buildings 2024: € 313,052 ▼ 10% vs 2023 (€ 349,589) Unchanged	€ 415,330 Land & buildings 2025: € 415,330 ▲ 33% vs 2024 (€ 313,052) Unchanged	€ 415,027 Land & buildings 2026: € 415,027 Unchanged (€ 415,330) Unchanged
Retained profit	€ 269,011 Retained profit 2023: € 269,011 First fiscal year in the series	€ 199,531 Retained profit 2024: € 199,531 ▼ 26% vs 2023 (€ 269,011) Unfavourable step	€ 58,056 Retained profit 2025: € 58,056 ▼ 71% vs 2024 (€ 199,531) Unfavourable step	€ -42,781 Retained profit 2026: € -42,781 ▼ € 100,836 vs 2025 (€ 58,056) Unfavourable step	▼ € 100,836
Dividend	€ 64,105 Dividend 2023: € 64,105 First fiscal year in the series	€ 106,407 Dividend 2024: € 106,407 ▲ 66% vs 2023 (€ 64,105) Unchanged	€ 117,581 Dividend 2025: € 117,581 ▲ 11% vs 2024 (€ 106,407) Unchanged	€ 0 Dividend 2026: € 0 ▼ 100% vs 2025 (€ 117,581) Unchanged	▼ 100%
Bank debt	€ 437,002 Bank debt 2023: € 437,002 First fiscal year in the series	€ 367,887 Bank debt 2024: € 367,887 ▼ 16% vs 2023 (€ 437,002) Favourable step	€ 589,018 Bank debt 2025: € 589,018 ▲ 60% vs 2024 (€ 367,887) Unfavourable step	€ 488,792 Bank debt 2026: € 488,792 ▼ 17% vs 2025 (€ 589,018) Favourable step	▼ 17%
Balance sheet total	€ 810,264 Balance sheet total 2023: € 810,264 First fiscal year in the series	€ 713,978 Balance sheet total 2024: € 713,978 ▼ 12% vs 2023 (€ 810,264) Unchanged	€ 813,946 Balance sheet total 2025: € 813,946 ▲ 14% vs 2024 (€ 713,978) Unchanged	€ 510,516 Balance sheet total 2026: € 510,516 ▼ 37% vs 2025 (€ 813,946) Unchanged	▼ 37%

Key figures of RADIOLOGIE SCHEPENS, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to RADIOLOGIE SCHEPENS?

What happened at RADIOLOGIE SCHEPENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 6, 2026 New annual accounts for financial year 2026: loss of € 100,836. Source: NBB ↗
Sep 17, 2007 Incorporation, published in the Gazette. Source: Staatsblad ↗
Sep 13, 2007 New establishment in Gent. KBO

In short

From € 45,022 profit in 2023 to € 100,836 loss in 2026.

Paid € 32,578 in corporate taxes since 2023.

Best year ever: 2023, with € 45,022 profit.

Paid out € 288,093 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Filiz Özsarlak Elisabeth Schepens

RADIOLOGIE SCHEPENS

Behind RADIOLOGIE SCHEPENS are Filiz Özsarlak and Elisabeth Schepens.

Directors

According to the 2026 annual accounts

Filiz Özsarlak

Director

Elisabeth Schepens

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Tentoonstellingslaan 95

9000 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

17 September 2007 Source: Deed ↗

SCHEPENS Elisabeth(enige oprichter) 100%

Details

Company number

0892.033.081

VAT number

BE 0892.033.081

Registered office

Tentoonstellingslaan 95, 9000 Gent

Names & denominations

RADIOLOGIE SCHEPENS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

13 September 2007

Peppol

Active · Active since 12 Nov 2025

Activities · NACE

Activiteiten van medisch specialisten

Medische praktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

RADIOLOGIE SCHEPENS

Warning lights

Financials

What happened to RADIOLOGIE SCHEPENS?

Management

Directors

Establishments

Establishment units

Shareholders according to the Official Gazette deeds

Details

Frequently asked questions